Abstract
Glucocorticoids (GCs) are potent anti-inflammatory drugs. A new study by Auger et al. found that GCs increase itaconate, an anti-inflammatory tricarboxylic acid (TCA) cycle intermediate, by promoting movement of cytosolic pyruvate dehydrogenase (PDH) to mitochondria. Itaconate was sufficient for mediating the anti-inflammatory effects of GCs in mice, overriding the notion that nuclear glucocorticoid receptor (GR) is necessary for inflammation inhibition.
| Original language | English |
|---|---|
| Pages (from-to) | 99-101 |
| Number of pages | 3 |
| Journal | Trends in Endocrinology and Metabolism |
| Volume | 36 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 2025 |
Keywords
- GR
- LPS
- PDH
- itaconate
- macrophage
All Science Journal Classification (ASJC) codes
- Endocrinology, Diabetes and Metabolism
- Endocrinology